Dynamics of Adrenal Steroids Are Related to Variations in Th1 and Treg Populations during Mycobacterium tuberculosis Infection in HIV Positive Persons

Tuberculosis (TB) remains the most frequent cause of illness and death from an infectious agent, and its interaction with HIV has devastating effects. We determined plasma levels of dehydroepiandrosterone (DHEA), its circulating form DHEA-suphate (DHEA-s) and cortisol in different stages of M. tuberculosis infection, and explored their role on the Th1 and Treg populations during different scenarios of HIV-TB coinfection, including the immune reconstitution inflammatory syndrome (IRIS), a condition related to antiretroviral treatment. DHEA levels were diminished in HIV-TB and HIV-TB IRIS patients compared to healthy donors (HD), HIV+ individuals and HIV+ individuals with latent TB (HIV-LTB), whereas dehydroepiandrosterone sulfate (DHEA-s) levels were markedly diminished in HIV-TB IRIS individuals. HIV-TB and IRIS patients presented a cortisol/DHEA ratio significantly higher than HIV+, HIV-LTB and HD individuals. A positive correlation was observed between DHEA-s and CD4 count among HIV-TB individuals. Conversely, cortisol plasma level inversely correlated with CD4 count within HIV-TB individuals. M. tuberculosis-specific Th1 lymphocyte count was increased after culturing PBMC from HIV-TB individuals in presence of DHEA. We observed an inverse correlation between DHEA-s plasma level and Treg frequency in co-infected individuals, and CD4+FoxP3+ Treg frequency was increased in HIV-TB and IRIS patients compared to other groups. Strikingly, we observed a prominent CD4+CD25-FoxP3+ population across HIV-TB and HIV-TB IRIS patients, which frequency correlated with DHEA plasma level. Finally, DHEA treatment negatively regulated FoxP3 expression without altering Treg frequency in co-infected patients. These data suggest an enhancing role for DHEA in the immune response against M. tuberculosis during HIV-TB coinfection and IRIS.

[1]  G. Cheng,et al.  Vitamin D Is Required for IFN-γ–Mediated Antimicrobial Activity of Human Macrophages , 2011, Science Translational Medicine.

[2]  C. Riccardi,et al.  CD4+CD25lowGITR+ cells: A novel human CD4+ T‐cell population with regulatory activity , 2011, European journal of immunology.

[3]  D. Boulware,et al.  Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. , 2011, The Journal of infectious diseases.

[4]  M. Mendelson,et al.  Pulmonary manifestations of the immune reconstitution inflammatory syndrome , 2011, Current opinion in pulmonary medicine.

[5]  A. Rudensky,et al.  Regulatory T cells and Foxp3 , 2011, Immunological reviews.

[6]  G. Carcelain,et al.  Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus. , 2011, Trends in immunology.

[7]  Z. Toossi,et al.  Distinct cytokine and regulatory T cell profile at pleural sites of dual HIV/tuberculosis infection compared to that in the systemic circulation , 2011, Clinical and experimental immunology.

[8]  L. Xiang,et al.  Immunomodulatory Effects of in vitroStress Hormones on FoxP3, Th1/Th2 Cytokine and Costimulatory Molecule mRNA Expression in Human Peripheral Blood Mononuclear Cells , 2010, Neuroimmunomodulation.

[9]  D. Hafler,et al.  FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.

[10]  D. Horwitz.  Identity of mysterious CD4+CD25-Foxp3+ cells in SLE , 2010, Arthritis research & therapy.

[11]  D. Horwitz.  Identity of mysterious CD4+CD25-Foxp3+cells in systemic lupus erythematosus , 2010 .

[12]  Wei He,et al.  Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells? , 2009, Arthritis research & therapy.

[13]  A. Cooper.  T cells in mycobacterial infection and disease. , 2009, Current opinion in immunology.

[14]  D. Cooper,et al.  Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over‐active CD4+ T‐cell responses in HIV‐positive patients with mycobacterial immune restoration disease , 2009, European journal of immunology.

[15]  O. Bottasso,et al.  The Impact of Infectious Diseases upon Neuroendocrine Circuits , 2009, Neuroimmunomodulation.

[16]  J. Smolen,et al.  Phenotypic and Functional Analysis of CD4+CD25−Foxp3+ T Cells in Patients with Systemic Lupus Erythematosus1 , 2009, The Journal of Immunology.

[17]  R. Loria.  Beta-Androstenes and Resistance to Viral and Bacterial Infections , 2009, Neuroimmunomodulation.

[18]  S. Oka,et al.  High frequency and proliferation of CD4+FOXP3+ Treg in HIV‐1‐infected patients with low CD4 counts , 2009, European journal of immunology.

[19]  G. Maartens,et al.  Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. , 2008, American journal of respiratory and critical care medicine.

[20]  P. Reiss,et al.  Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. , 2008, The Lancet. Infectious diseases.

[21]  Sugata Roy,et al.  Mannose‐capped lipoarabinomannan‐ and prostaglandin E2‐dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection , 2008, European journal of immunology.

[22]  H. Salomón,et al.  Magnitude, Breadth, and Functional Profile of T-Cell Responses during Human Immunodeficiency Virus Primary Infection with B and BF Viral Variants , 2008, Journal of Virology.

[23]  O. Bottasso,et al.  The Immuno‐endocrine Component in the Pathogenesis of Tuberculosis , 2007, Scandinavian journal of immunology.

[24]  O. Bottasso,et al.  Altered Cortisol/DHEA Ratio in Tuberculosis Patients and its Relationship with Abnormalities in the Mycobacterial‐driven Cytokine Production by Peripheral Blood Mononuclear Cells , 2007, Scandinavian journal of immunology.

[25]  Armando Garsd,et al.  Safety and Activity of the Immune Modulator HE2000 on the Incidence of Tuberculosis and Other Opportunistic Infections in AIDS Patients , 2007, Antimicrobial Agents and Chemotherapy.

[26]  Xinchun Chen,et al.  CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. , 2007, Clinical immunology.

[27]  O. Bottasso,et al.  Endocrine and cytokine responses in humans with pulmonary tuberculosis , 2007, Brain, Behavior, and Immunity.

[28]  A. Garsd,et al.  Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000). , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  A. Rudensky,et al.  Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Lalvani,et al.  Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. , 2006, American journal of respiratory and critical care medicine.

[31]  Z. Toossi,et al.  A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis , 2006, Clinical and experimental immunology.

[32]  E. Vicaut,et al.  Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients , 2006, AIDS.

[33]  A. Coles,et al.  Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells , 2005, European journal of immunology.

[34]  Alimuddin Zumla,et al.  Immune responses to tuberculosis in developing countries: implications for new vaccines , 2005, Nature Reviews Immunology.

[35]  S. Lawn,et al.  Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. , 2005, The Lancet. Infectious diseases.

[36]  J. S. Dillon.  Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. , 2005, Current drug targets. Inflammation and allergy.

[37]  G. Rook,et al.  16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis. , 2005, The Journal of infectious diseases.

[38]  C. Akdis,et al.  Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. , 2004, The Journal of allergy and clinical immunology.

[39]  Takashi Suzuki,et al.  Dissecting human adrenal androgen production , 2002, Trends in Endocrinology & Metabolism.

[40]  G. Chrousos,et al.  Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease , 1999, Trends in Endocrinology & Metabolism.

[41]  J. J. Henning,et al.  Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 , 1998, HIV clinical trials.

[42]  N. Christeff,et al.  Serum cortisol and DHEA concentrations during HIV infection , 1997, Psychoneuroendocrinology.

[43]  S. K. Ardestani,et al.  Modulation of immune dysfunction during murine leukaemia retrovirus infection of old mice by dehyroepiandrosterone sulphate (DHEAS) , 1997, Immunology.

[44]  H. Besedovsky,et al.  Immune-neuro-endocrine interactions: facts and hypotheses. , 1996, Endocrine reviews.

[45]  R. Daynes,et al.  Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines. , 1994, Endocrinology.

[46]  P. Cardona.  Revisiting the Natural History of Tuberculosis The Inclusion of Constant Reinfection , Host Tolerance , and Damage-Response Frameworks Leads to a Better Understanding of Latent Infection and its Evolution towards Active Disease , 2010 .

[47]  G. Van den Berghe.  Endocrine evaluation of patients with critical illness. , 2003, Endocrinology and metabolism clinics of North America.

[48]  G. Rook,et al.  T cell helper types and endocrines in the regulation of tissue-damaging mechanisms in tuberculosis. , 1994, Immunobiology.